Clinical Trial Update: Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

View source ↗

Summary

An AstraZeneca-sponsored clinical trial in the Russian Federation is evaluating treatment approaches and biomarker prevalence in patients with de novo metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Status: RECRUITING